PMC:7361216 / 5473-5622 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7361216","sourcedb":"PMC","sourceid":"7361216","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7361216","text":"Reductions in antibody were sustained for as long as 96 hr, demonstrating the pharmacologic feasibility of this highly specific therapeutic approach.","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T69","span":{"begin":14,"end":22},"obj":"Body_part"}],"attributes":[{"id":"A69","pred":"fma_id","subj":"T69","obj":"http://purl.org/sig/ont/fma/fma62871"},{"subj":"T69","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-sample-sentences","denotations":[{"id":"T33","span":{"begin":0,"end":149},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T33","pred":"source","obj":"LitCovid-sample-sentences"}]},{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T69","span":{"begin":14,"end":22},"obj":"Body_part"}],"attributes":[{"id":"A69","pred":"fma_id","subj":"T69","obj":"http://purl.org/sig/ont/fma/fma62871"},{"subj":"T69","pred":"source","obj":"LitCovid-sample-PD-FMA"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T33","span":{"begin":0,"end":149},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T33","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#ecdc93","default":true},{"id":"LitCovid-sample-sentences","color":"#c293ec"},{"id":"LitCovid-sample-PD-FMA","color":"#93eca8"},{"id":"LitCovid-sentences","color":"#ec9397"}]}]}}